Deborah B. Doroshow

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper et al. · Annals of Oncology · 2021 · 326 citations · Full text

Medicine, Infectious Diseases, Oncology +10

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 218 citations · Full text

Medicine, Oncology, Chemotherapy +13

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Hematology, Oncology +10

An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

Nelson M. LaMarche, Samarth Hegde, Matthew D. Park et al. · Nature · 2023 · 184 citations · Full text

Life Sciences, Cell Biology, Immunology +16